All In Biotech

Free tool

FAERS Monitor: Tyvaso Dpi

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214324 or its brand name (Tyvaso Dpi, Treprostinil). Reports on generic versions are filed under their own applications.

Reports

17,039

Serious

9,139

54% of reports

Hospitalization

6,069

Death reported

1,531

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • cough3,755
  • dyspnoea3,545
  • headache3,034
  • diarrhoea2,400
  • dizziness1,892
  • fatigue1,876
  • nausea1,861
  • oxygen saturation decreased1,205
  • hypotension1,102
  • vomiting905
  • dyspnoea exertional898
  • throat irritation822
  • death784
  • asthenia773
  • weight decreased766

Reports by year received

View as table
YearReports
20051
20063
20071
20082
20098
201013
201122
201240
201342
201471
2015146
201690
2017103
2018101
2019456
2020481
2021624
20221,250
20233,218
20243,476
20254,083
20262,808

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,120 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
dyspnoea exertionalSignal89830.128.224,699
oxygen saturation decreasedSignal1,20527.025.629,606
throat irritationSignal82223.021.517,011
coughSignal3,75516.716.355,551
dyspnoeaSignal3,5457.87.521,357
hypotensionSignal1,1026.86.45,483
headacheSignal3,0346.05.812,955
dizzinessSignal1,8924.74.55,613
diarrhoeaSignal2,4004.64.46,953
weight decreasedSignal7663.43.21,305
fatigueSignal1,8763.02.92,553
nauseaSignal1,8612.92.82,411
astheniaSignal7732.52.4732
vomitingSignal9052.42.2737
death7841.11.011

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.